Using the PREVENT-CVD equation to guide management of high blood pressure could improve outcomes by identifying individuals at increased cardiovascular risk, researchers reported.The American Heart ...

New partnership will join others to expand access to generic lenacapavir for millions more people at risk of HIV in high-burden countries—bringing the world closer to ending the epidemic - Kenya ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

Spine and orthopedic surgeon explains having a bone-healthy diet and limiting unhealthy habits like smoking and drinking alcohol can prevent fracture risk.

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce infections significantly.

An HIV prevention drug will be made available at a new, low cost in 120 low- and middle-income countries starting in 2027, according to an announcement yesterday. The move is being called a “once-in-a ...

Zimbabwe has been chosen as one of only ten countries in the world to introduce lenacapavir, a revolutionary HIV prevention drug that health experts say could transform global efforts to end new ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a move that could bring the world closer to ending the HIV/AIDS epidemic.

Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...